Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces U.S. Product Launch of Vivamune

Accesswire July 9, 2013

Avivagen Announces Sales in Thailand

TheNewsWire June 25, 2013

Avivagen Announces CEO Update Letter

TheNewsWire June 17, 2013

Avivagen Receives U.S. Re-Orders For Oximunolâ?¢ Supplement

TheNewsWire May 9, 2013

Avivagen Improves Financial Position

TheNewsWire April 25, 2013

Avivagen Announces Approval for Extension of Warrants

TheNewsWire April 23, 2013

Avivagen Converts Liabilities and Extends Warrants

TheNewsWire April 12, 2013

Avivagen Patent Applications Allowed in Indonesia and Mexico

TheNewsWire April 5, 2013

Avivagen Announces Options Grants

TheNewsWire March 11, 2013

Avivagen Appoints New Chief Executive Officer and President

TheNewsWire March 11, 2013

Avivagen Inc. Completes Private Placement with Institutional Investors

TheNewsWire March 5, 2013

Avivagen Attends the 2013 International Production & Processing Expo in Atlanta, Georgia

TheNewsWire February 7, 2013

Avivagen Provides Corporate Update

TheNewsWire January 30, 2013